Citations
537 citation(s) found for "Gangat, Naseema".
Clinical and prognostic impact of STAG2 mutations in myeloid neoplasms: the Mayo Clinic experience
Katamesh, Bahga , Nanaa, Ahmad , He, Rong , Viswanatha, David S., Nguyen, Phuong L., Greipp, Patricia T. , Bessonen, Kurt, Gangat, Naseema , Begna, Kebede H. , Mangaonkar, Abhishek A. , Patnaik, Mrinal M. , Tefferi, Ayalew , Litzow, Mark R. , Foran, James M. , Badar, Talha , Al‐Kali, Aref , Viswanatha, David, Greipp, Patricia T , Begna, Kebede , Patnaik, Mrinal , Litzow, Mark R. , Shah, Mithun V , Arana Yi, Cecilia , Badar, Talha , Al-Kali, Aref , Nanaa, Ahmad , Hogan, William J. , Shah, Meera , Yi, Cecilia Arana , Alkhateeb, Hassan B.
Blood Advances | December 7, 2022 | Volume: 7 | Issue: 8 | Pages: 1351-1355
Molecular Predictors of Response and Survival in Patients with Relapsed/Refractory Acute Myeloid Leukemia Following Venetoclax Plus Hypomethylating Agent Therapy
Johnson, Isla McKerrow , Ilyas, Rimal, Al‐Kali, Aref , Begna, Kebede H. , Mangaonkar, Abhishek A. , Litzow, Mark R. , Patnaik, Mrinal M. , Pardanani, Animesh , Tefferi, Ayalew , Gangat, Naseema , McCullough, Kristen , Alkhateeb, Hassan B. , Hogan, William J. , Shah, Meera
Blood | November 29, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 3233-3234
Characteristics and Outcomes of Patients with BCOR Mutated Myeloid Neoplasms
Barua, Amit , Yıkılmaz, Aysun Şentürk , He, Rong , Viswanatha, David S., Katamesh, Bahga , Mangaonkar, Abhishek A. , Gangat, Naseema , Patnaik, Mrinal M. , Litzow, Mark R. , Begna, Kebede H. , Tefferi, Ayalew , Al‐Kali, Aref , Baranwal, Anmol , Shah, Meera , Badar, Talha , Hogan, William J. , Alkhateeb, Hassan B.
Blood | November 29, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 3235-3236
Determinants of Survival and Retrospective Comparisons in 183 Clinical Trial Patients with Myelofibrosis Treated with Ruxolitinib, Fedratinib, Momelotinib, or BMS-911543 JAK2 Inhibitor between 2007 and 2013
Gangat, Naseema , Begna, Kebede H. , Al‐Kali, Aref , Litzow, Mark R. , Pardanani, Animesh , Tefferi, Ayalew , Hogan, William J.
Blood | November 29, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 3945-3946
Therapy-Related Myelodysplastic Syndromes with Isolated Del(5q): Comparative Analysis of Phenotype and Long-Term Survival
Fleti, Farah, Singh, Amritpal , Al‐Kali, Aref , Foran, James M. , Elliott, Michelle A. , Begna, Kebede H. , Khera, Nandita , Abdelmagid, Maymona, Reichard, Kaaren K. , Pardanani, Animesh , Gangat, Naseema , Tefferi, Ayalew , Badar, Talha , Shah, Meera , Alkhateeb, Hassan B. , Ketterling, Rhett P.
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 6940-6941
Predictors of Response to Venetoclax Plus Hypomethylating Agent Therapy and Survival in Blast-Phase Myeloproliferative Neoplasm
Gangat, Naseema , Ilyas, Rimal, Begna, Kebede H. , Al‐Kali, Aref , Patnaik, Mrinal M. , Litzow, Mark R. , Mangaonkar, Abhishek A. , Elliott, Michelle A. , Foran, James M. , Palmer, Jeanne , Hanson, Curtis A. , Pardanani, Animesh , Tefferi, Ayalew , McCullough, Kristen , Hogan, William J. , Alkhateeb, Hassan B. , Shah, Meera , Badar, Talha
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 9675-9676
Clinical and Genetic Characteristics of STAG2 Mutations in Myeloid Neoplasms
Katamesh, Bahga , Nanaa, Ahmad , He, Rong , Viswanatha, David S., Nguyen, Phuong L., Bessonen, Kurt, Gangat, Naseema , Begna, Kebede H. , Mangaonkar, Abhishek A. , Patnaik, Mrinal M. , Tefferi, Ayalew , Litzow, Mark R. , Foran, James M. , Al‐Kali, Aref , Greipp, Patricia T. , Hogan, William J. , Shah, Meera , Yi, Cecilia Arana , Badar, Talha , Alkhateeb, Hassan B.
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 12353-12354
Reappraisal of Mast Cell Leukemia Based on a Single Institution Review of 16 Cases: Role of Mast Cell Morphology in Determining Clinical Outcome
Pardanani, Animesh , Tefferi, Ayalew , Singh, Amritpal , Al‐Kali, Aref , Patnaik, Mrinal M. , Begna, Kebede, Elliott, Michelle A. , Khera, Nandita , Palmer, Jeanne , Gangat, Naseema , Kelemen, Katalin, Reichard, Kaaren K. , Hogan, William J. , Orazi, Attilio , Chen, Dong
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 6872-6873
Differential Impact on Survival in Myeloid Neoplasm Patients with U2AF1 Mutations
Vanegas, Yenny Moreno , Nanaa, Ahmad , Al‐Kali, Aref , He, Rong , Patnaik, Mrinal M. , Gangat, Naseema , Litzow, Mark R. , Tefferi, Ayalew , Alkhateeb, Hassan B. , Shah, Meera , Badar, Talha
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 9602-9603
TP53 Mutation Status Defines a Distinct Clinicopathological Entity of Therapy-Related Myeloid Neoplasm, Characterized By Genomic Instability and Extremely Poor Outcome
Sharplin, Kirsty, Chhetri, Rakchha , Ladon, Dariusz, Al‐Kali, Aref , Litzow, Mark R. , Mangaonkar, Abhishek A. , Gangat, Naseema , Patnaik, Mrinal M. , Begna, Kebede, Tefferi, Ayalew , Shah, Meera , Hahn, Christopher N , Tran, Elizabeth Ngoc Hoa , Baranwal, Anmol , Kutyna, Monika , Wang, Paul Po-Shen , Alkhateeb, Hassan B. , Ross, David M , Yeung, David , Shanmuganathan, Naranie , Hogan, William J. , Kumar, Sharad , Singhal, Deepak , Brown, Anna , Scott, Hamish S. , THOMAS, DANIEL W. , Kok, Chung Hoow , Hiwase, Devendra
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 9798-9799